Immunic, Inc. SEC filings IMUX

Immunic, Inc. has 832 filings in SEC EDGAR's recent list, going back to Feb 18, 2004. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Immunic, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
S-8 Employee stock plan registration Oct 1, 2026 —
8-K Current report
Officer or director change
Sep 11, 2026 Sep 10, 2026
8-K Current report
Regulation FD disclosure
Sep 9, 2026 Sep 9, 2026
S-8 Employee stock plan registration Aug 12, 2026 —
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Aug 11, 2026 Aug 6, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jul 6, 2026 Jun 29, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 29, 2026 Jun 29, 2026
DEF 14A Proxy statement May 29, 2026 Jun 29, 2026
8-K Current report
Regulation FD disclosure
May 28, 2026 May 28, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 27, 2026 May 22, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 19, 2026 May 16, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
EFFECT Filing May 4, 2026 —
CORRESP Letter to the SEC May 1, 2026 —
S-3/A Filing Apr 30, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 28, 2026 Apr 24, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 23, 2026 Apr 22, 2026
10-K/A Amended annual report Apr 22, 2026 Dec 31, 2025
8-K Current report
Shareholder vote results, Other events
Apr 14, 2026 Apr 14, 2026
8-K Current report
Officer or director change
Apr 10, 2026 Apr 7, 2026
S-8 Employee stock plan registration Apr 9, 2026 —
UPLOAD Letter from the SEC Apr 6, 2026 —
S-3 Shelf registration Apr 2, 2026 —
8-K Current report
Other events
Apr 1, 2026 Mar 27, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 31, 2026 Mar 27, 2026
D Filing Mar 4, 2026 —
DEF 14A Proxy statement Mar 2, 2026 Apr 14, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
PRE 14A Preliminary proxy statement Feb 20, 2026 Apr 14, 2026
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Feb 13, 2026 Feb 12, 2026
8-K Current report
Listing notice
Jan 6, 2026 Jan 5, 2026
8-K Current report
Officer or director change
Jan 5, 2026 Dec 29, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 25, 2025 Sep 25, 2025
S-8 Employee stock plan registration Aug 27, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change
Jul 11, 2025 Jul 7, 2025
8-K Current report
Listing notice
Jun 27, 2025 Jun 27, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2025 Jun 4, 2025
8-K Current report
Material agreement, Regulation FD disclosure
May 30, 2025 May 28, 2025
424B5 Prospectus supplement May 30, 2025 —
424B5 Prospectus supplement May 28, 2025 —
8-K Current report
Other events
May 28, 2025 May 28, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Other events
Apr 30, 2025 Apr 30, 2025
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 4, 2025
424B5 Prospectus supplement Apr 9, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 9, 2025 Apr 9, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Other events
Feb 20, 2025 Feb 20, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Dec 18, 2024 Dec 13, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Oct 22, 2024 Oct 22, 2024
8-K Current report
Other events
Sep 10, 2024 Sep 10, 2024
8-K Current report
Material agreement
Sep 3, 2024 Aug 29, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Other events
Aug 8, 2024 Aug 8, 2024
8-K Current report
Officer or director change
Jul 24, 2024 Jul 21, 2024
8-K Current report
Officer or director change
Jul 9, 2024 Jul 9, 2024
S-8 Employee stock plan registration Jul 2, 2024 —
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 11, 2024
424B5 Prospectus supplement Jun 10, 2024 —
EFFECT Filing May 31, 2024 —
CORRESP Letter to the SEC May 29, 2024 —
S-3/A Pre-effective amendment no. 1 to form s-3 May 24, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations, Other events
May 8, 2024 May 8, 2024
EFFECT Filing Apr 30, 2024 —
424B3 Prospectus Apr 30, 2024 —
CORRESP Letter to the SEC Apr 26, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 11, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Mar 8, 2024 Mar 4, 2024
S-3/A Filing Mar 1, 2024 —
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Feb 22, 2024 Feb 22, 2024
UPLOAD Letter from the SEC Feb 21, 2024 —
S-3 Shelf registration Feb 13, 2024 —
DEF 14A Proxy statement Feb 5, 2024 Mar 4, 2024
PRE 14A Preliminary proxy statement Jan 24, 2024 Mar 4, 2024
D Filing Jan 19, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jan 5, 2024 Jan 4, 2024
8-K Current report
Officer or director change
Dec 21, 2023 Dec 18, 2023
UPLOAD Letter from the SEC Nov 30, 2023 —
S-3 Shelf registration Nov 22, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations, Other events
Nov 14, 2023 Nov 14, 2023
8-K Current report
Material agreement
Oct 18, 2023 Oct 17, 2023
8-K Current report
Other events
Oct 10, 2023 Oct 9, 2023
S-8 Employee stock plan registration Aug 21, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Aug 3, 2023 Aug 3, 2023
8-K Current report
Shareholder vote results
Jun 30, 2023 Jun 28, 2023
8-K Current report
Results of operations, Other events
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
May 4, 2023 May 4, 2023
DEF 14A Proxy statement May 1, 2023 Jun 28, 2023
8-K Current report
Officer or director change
Apr 27, 2023 Apr 26, 2023
8-K Current report
Other events
Apr 5, 2023 Apr 5, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Feb 23, 2023 Feb 23, 2023
8-K Current report
Other events
Feb 9, 2023 Feb 9, 2023
8-K Current report
Officer or director change
Jan 20, 2023 Jan 16, 2023
8-K Current report
Material agreement
Dec 30, 2022 Dec 28, 2022
EFFECT Filing Dec 20, 2022 —
424B3 Prospectus Dec 20, 2022 —
CORRESP Letter to the SEC Dec 16, 2022 —
UPLOAD Letter from the SEC Dec 15, 2022 —
S-3 Shelf registration Dec 9, 2022 —
8-K Current report
Other events
Nov 17, 2022 Nov 17, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations, Other events
Nov 3, 2022 Nov 3, 2022
8-K Current report
Other events
Oct 20, 2022 Oct 20, 2022
D Filing Oct 18, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 11, 2022 Oct 10, 2022
8-K Current report
Other events
Sep 20, 2022 Sep 20, 2022
8-K/A Amended current report
Other events
Aug 4, 2022 Aug 4, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations, Other events
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 8, 2022 Jul 5, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 15, 2022
8-K Current report
Other events
Jun 2, 2022 Jun 2, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2022 May 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Material agreement
May 2, 2022 May 2, 2022
424B5 Prospectus supplement May 2, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 15, 2022
8-K Current report
Regulation FD disclosure
Apr 21, 2022 Apr 21, 2022
8-K Current report
Material agreement, Officer or director change
Mar 16, 2022 Mar 10, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations, Other events
Feb 24, 2022 Feb 24, 2022
8-K Current report
Other events
Feb 18, 2022 Feb 18, 2022
8-K Current report
Officer or director change, Other events
Jan 10, 2022 Jan 5, 2022
8-K Current report
Other events
Dec 14, 2021 Dec 14, 2021
8-K Current report
Results of operations, Other events
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Oct 15, 2021 Oct 14, 2021
8-K Current report
Results of operations
Aug 6, 2021 Aug 6, 2021
10-Q Quarterly report Aug 6, 2021 Jun 30, 2021
S-8 Employee stock plan registration Jul 28, 2021 —
8-K Current report
Material agreement
Jul 19, 2021 Jul 15, 2021
424B5 Prospectus supplement Jul 16, 2021 —
424B5 Prospectus supplement Jul 14, 2021 —
8-K Current report
Other events
Jul 12, 2021 Jul 12, 2021
8-K Current report
Other events
Jul 12, 2021 Jul 12, 2021
8-K Current report
Other events
Jul 1, 2021 Jul 1, 2021
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 14, 2021 Jun 10, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
EFFECT Filing May 5, 2021 —
CORRESP Letter to the SEC May 3, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 10, 2021
UPLOAD Letter from the SEC Apr 22, 2021 —
8-K Current report
Material agreement, Officer or director change
Apr 19, 2021 Apr 15, 2021
S-3 Shelf registration Apr 16, 2021 —
8-K Current report
Material agreement, Unregistered share sale
Mar 31, 2021 Mar 31, 2021
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Results of operations, Other events
Feb 26, 2021 Feb 26, 2021
8-K Current report
Other events
Feb 18, 2021 Feb 17, 2021
8-K Current report
Material agreement
Jan 4, 2021 Dec 29, 2020
424B5 Prospectus supplement Dec 29, 2020 —
EFFECT Filing Nov 24, 2020 —
CORRESP Letter to the SEC Nov 20, 2020 —
UPLOAD Letter from the SEC Nov 20, 2020 —
S-3 Shelf registration Nov 13, 2020 —
8-K/A Amended current report
Material agreement
Nov 13, 2020 Apr 23, 2020
424B5 Prospectus supplement Nov 12, 2020 —
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Oct 20, 2020 Oct 19, 2020
8-K Current report
Regulation FD disclosure
Sep 11, 2020 Sep 11, 2020
8-K Current report
Material agreement, Other events
Aug 7, 2020 Aug 4, 2020
424B5 Prospectus supplement Aug 5, 2020 —
424B5 Prospectus supplement Aug 4, 2020 —
424B5 Prospectus supplement Aug 3, 2020 —
10-Q/A Amended quarterly report Aug 3, 2020 Jun 30, 2020
10-Q Quarterly report Aug 3, 2020 Jun 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 3, 2020 Aug 2, 2020
8-K Current report
Regulation FD disclosure
Jul 27, 2020 Jul 27, 2020
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jul 7, 2020 Jul 2, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 15, 2020
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jun 12, 2020 Jun 9, 2020
424B5 Prospectus supplement Jun 11, 2020 —
424B5 Prospectus supplement Jun 10, 2020 —
8-K Current report
Other events
May 19, 2020 May 19, 2020
8-K Current report
Other events
May 13, 2020 May 13, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 8, 2020 May 8, 2020
DEF 14A Proxy statement Apr 29, 2020 Jul 2, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Apr 27, 2020 Apr 23, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMUX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, United States
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1280776
Former names
VITAL THERAPIES INC (until Apr 10, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.